Barings Korean Equity was the best-performing fund in October 2025, with Korea, emerging markets, technology, and biotechnology outperforming. Four of the top 10 funds are also among the best performers for the year so far. Chetan Sehgal, portfolio manager of Templeton Emerging Markets Investment Trust, noted that emerging markets have stabilized amid US dollar weakness and a clearer global trade landscape.

Korean equity funds dominated the list of best performers in 2025, with the Korea equity Morningstar Category growing by 20% in October alone. The Korean Kospi index hit new highs in October, benefiting from developments in AI. The four best performing funds this month include Barings Korean Equity, JPMorgan Korea, and Macquarie Emerging Markets, all among the top 20 performers for the year.

In October, the Barings Korean Equity fund rose 20.53%, in line with the average fund in the Korea equity category. The JPMorgan Korea fund rose 20.05%, and Macquarie Emerging Markets rose 15.37%. Other top performers include Polar Capital Global Technology, Heptagon Driehaus US Micro Cap Equity Fund, Pictet Biotech, Polar Capital Biotechnology, Herald Worldwide Technology, Candriam Biotechnology Equities, and Janus Henderson Global Life Sciences Equity.

The Polar Capital Global Technology fund rose 15.27% in October, outperforming the average equity technology fund. The Heptagon Driehaus US Micro Cap Equity Fund gained 14.16%, while the Pictet Biotech fund rose 14.02%. Additionally, the Polar Capital Biotechnology fund increased by 13.92%, the Herald Worldwide Technology fund by 13.78%, the Candriam Biotechnology Equities fund by 13.31%, and the Janus Henderson Global Life Sciences Equity fund by 13.22%.

The best-performing funds in Q3 2025 were highlighted, showcasing the success of various funds across different categories. This article was generated with the help of automation and reviewed by Morningstar editors. The authors do not own shares in any securities mentioned in the article, maintaining Morningstar’s editorial policies.

Read more at Morningstar: The Best-Performing Funds in October 2025